ZYC101a for treatment of high-grade cervical intraepithelial neoplasia: a randomized controlled trial.

Obstetrics and gynecology

Volumn 103, Issue 2, 2004, Pages 317-326

  Garcia, Francisco ^a   Petry, Karl Ulrich ^a   Muderspach, Laila ^a   Gold, Michael A ^a   Braly, Patricia ^a   Crum, Christopher P ^a   Magill, Marianne ^a   Silverman, Michael ^a   Urban, Robert G ^a   Hedley, Mary Lynne ^a   Beach, Kathleen J ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; DNA; ONCOPROTEIN; VIRUS PROTEIN; ZYC101A;

ADOLESCENT; ADULT; ARTICLE; CANCER STAGING; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG ADMINISTRATION; DRUG COMBINATION; FEMALE; FOLLOW UP; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; MIDDLE AGED; MULTICENTER STUDY; PATHOLOGY; PHASE 2 CLINICAL TRIAL; PROBABILITY; RANDOMIZED CONTROLLED TRIAL; REFERENCE VALUE; RISK ASSESSMENT; TREATMENT OUTCOME; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX TUMOR;

ADOLESCENT; ADULT; ANTINEOPLASTIC AGENTS; CERVICAL INTRAEPITHELIAL NEOPLASIA; DNA; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; DRUG COMBINATIONS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INJECTIONS, INTRAMUSCULAR; MIDDLE AGED; NEOPLASM STAGING; ONCOGENE PROTEINS, VIRAL; PROBABILITY; REFERENCE VALUES; RISK ASSESSMENT; TREATMENT OUTCOME; UTERINE CERVICAL NEOPLASMS; VIRAL PROTEINS;

EID: 1442305202     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.AOG.0000110246.93627.17     Document Type: Article

References (0)